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The osmosensitive transcription factor nuclear factor of activated T-cells 5 (NFAT5), also
known as tonicity enhancer element binding protein (TonEBP) plays a crucial role in
protection of renal medullary cells against hyperosmotic stress, urinary concentration, the
adaptive immune response, and other physiological systems. Since it is also important for
development, conventional homozygous-null mutations result in perinatal death, which
hinders the analysis of NFAT5 function in specific tissues in vivo. Here we describe
the generation of mice with a conditional-null allele, in which loxP sites are inserted
around exon 4. Mice harboring the floxed allele (NFAT5flx ) were mated to a strain
expressing a tamoxifen-inducible derivative of the Cre-recombinase (Cre+) under the
control of the ubiqitinC promoter. The resultant homozygous conditional knockout mice
(Cre+ NFAT5flx/flx ) are viable, fertile, and show normal expression of NFAT5 and NFAT5
target genes, indicating that the conditional alleles retain their wild-type function. Induction
of Cre-mediated recombination by administration of tamoxifen in 8-week-old mice resulted
in a decrease in NFAT5 expression of about 70–90% in all tested tissues (renal cortex,
renal outer medulla, renal inner medulla, heart, lung, spleen, skeletal muscle). Accordingly,
the expression of the NFAT5 target genes aldose reductase and heat shock protein 70
in the renal medulla was also significantly decreased. Mice harboring this conditional
knockout allele should be useful in future studies for gaining a better understanding of
tissue and cell-type specific functions of NFAT5 in adult animals under physiological and
pathophysiological conditions.
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INTRODUCTION
The osmosensitive transcription factor tonicity-responsive
enhancer binding protein (TonEBP) was first identified in renal
medullary cells. Based on its homology to nuclear factors of
activated T cells (NFAT) 1–4, TonEBP is also referred to as
NFAT5. NFAT5 drives the expression of various genes that are
important for the function of the renal medulla. On the one hand,
NFAT5 regulates the expression of central components of the
urinary concentrating mechanism, including the kidney-specific
ClC-K1 chloride channels and their functional subunit barttin
(Küper et al., 2012b), and UT-A1 urea transporters (Nakayama
et al., 2000). Accordingly, NFAT5 is a prerequisite for building
up the cortico-medullary osmotic gradient by the interstitial
accumulation of NaCl and urea in the renal papilla. NFAT5 is
further indispensible for the production of concentrated urine
during antidiuresis by virtue of its regulation of the transcription
of aquaporin-2 (AQP-2) water channels in collecting duct
principle cells (Hasler et al., 2006; Hasler, 2011). NFAT5 is,
moreover, essential for the osmoadaptation of cells in the renal
medulla. In this kidney region, NFAT5 stimulates the expression
of transporters and biosynthetic enzymes for cellular accumu-
lation of organic osmolytes. These include the Na-myo-inositol
cotransporter (SMIT) (Miyakawa et al., 1999), the Na-Cl-betaine
cotransporter (BGT1) (Miyakawa et al., 1998), the Na-Cl-taurine
cotransporter (TauT) (Ito et al., 2006), aldose reductase (AR)
(Nadkarni et al., 1999), specific heat shock proteins (Woo et al.,
2002), and others. The intracellular accumulation of organic
osmolytes and heat shock protein 70 (HSP70) protect cells from
the adverse effects of hypertonicity.
In past years, it has become increasingly apparent that, in addi-
tion to its role in the urinary concentration mechanism and in
protection against hyperosmotic stress, NFAT5 is also involved
in diverse other physiological and pathophysiological processes.
NFAT5 drives for instance the osmotic stress-induced expres-
sion of proinflammatory cytokines LT-β, Il-6, and TNF-α in
macrophages (Lopez-Rodriguez et al., 2001; Buxade et al., 2012)
and of the chemokine MCP-1 (CCL2) in epithelial cells during
inflammatory processes (Kojima et al., 2010; Roth et al., 2010;
Küper et al., 2012a), indicating that NFAT5 enhances the proin-
flammatory immune response under pathophysiological condi-
tions associated with hyperosmotic stress. In breast and colon
carcinoma, Integrin-mediated activation of NFAT5 stimulates the
expression of S100A4, thereby promoting metastatic activity of
tumor cells (Jauliac et al., 2002; Chen and O’Connor, 2005; Chen
et al., 2009, 2011). Knockdown of NFAT5 in T-lymphocytes chal-
lenged with osmotic stress results in downregulation of cyclins E1,
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A2, and B1, which is associated with cell cycle arrest (Drews-Elger
et al., 2009). In skeletal muscle cells, NFAT5 regulates expression
of Cyr61, thereby controlling migration and differentiation of
myoblasts (O’Connor et al., 2007). In the placenta, NFAT5 stimu-
lates the expression of SMIT, AR, and HSP70 (Arroyo et al., 2009,
2012; Park et al., 2014).
Most of these findings have been derived from cell culture
experiments. Conventional NFAT5 knockout mice show high
perinatal lethality due to impaired renal (Lopez-Rodriguez et al.,
2004) and heart (Mak et al., 2011) development. Furthermore,
these animals show an impaired immune response (Trama et al.,
2002; Go et al., 2004). Thus, conventional NFAT5 knockout mice
are of limited use for analysis of NFAT5 function in adult ani-
mals. The goal of the present study was to create a conditional
NFAT5 knockout allele to overcome the problems of conventional
NFAT5 knockout mice. For this purpose, we constructed a NFAT5
allele, in which exon 4 is flanked by loxP sequences (NFAT5flx).
Cre-mediated recombination of this allele leads to knockdown of
NFAT5. By mating NFAT5flx mice with a mouse strain expressing
a tamoxifen-inducible Cre recombinase, we generated a mouse
strain in which NFAT5 can be knocked down in adult animals
by tamoxifen administration.
MATERIALS AND METHODS
CONSTRUCTION OF A CONDITIONAL TARGETING VECTOR FOR NFAT5
The conditional NFAT5 allele was created in collaboration with
Ingenious Targeting Laboratory, Inc., (Stony Brook, NY, USA). A
8.26-Kb region from a positively identified C57BL/6 BAC clone
(RP23: 187J8) was used to construct the targeting vector. The
region was subcloned into a pSP72 vector (Promega, Madison,
WI, USA) containing an ampicillin selection cassette. The short
homology arm (SA) of the region was designed such that it
extended about 2.45 kb 3′ to exon 4 of the NFAT5 gene. The
long homology arm (LA) ended 5′ to exon 4, and was 5.25 kb
long. A pGK-gb2 loxP/frt Neo cassette was inserted 202 bp down-
stream from exon 4. The Neo cassette contained the promoter of
the mouse phosphoglucokinase gene, a neomycin resistance gene,
and a synthetic polyadenylation sequence, and was flanked by frt
sites for later excision by Flp recombinase. The cassette also con-
tained two loxP sites, one within the frt sites, and another one at
the 3′ end of the cassette, outside the frt sites. An additional sin-
gle loxP site (third loxP site), containing engineered KpnI, EcoRI,
MscI and StuI sites for southern blot analysis, was inserted 166
bp upstream from exon 4. The length of the target region was
561 bp and included exon 4; the total size of the targeting con-
struct (including vector backbone and Neo cassette) was 12.4 kb.
The targeting vector was confirmed by restriction analysis after
each modification step. P6 and T7 primers (see Table 1) anneal to
the vector sequence and read into the 5′ and 3′ ends of the BAC
sub clone. N1 and N2 primers anneal to the 5′ and 3′ ends of the
loxP/frt Neo cassette and sequence the SA and LA, respectively.
TARGETED ES CELLS AND GENERATION OF CHIMERIC MICE
The targeting vector (10μg) was linearized by NotI and
then transfected by electroporation of BA1(C57BL/6x129/SvEv)
hybrid embryonic stem (ES) cells. After selection with G418
antibiotic, surviving clones were expanded for PCR analysis
to identify recombinant ES clones. ES cell colonies were first
screened by PCR, using primers A1 or A2, binding downstream
from the SA, and the primer F3, binding within the Neo cassette.
Size of the resulting PCR products was 2.57 or 2.73 kb, respec-
tively. A control PCR reaction was performed using the 3′-primer
AT1 and the 5′-primer AT2, which bind downstream from theNeo
cassette within the SA. The size of the resulting PCR product was
2.25 kb.
PCR CONFIRMATION OF THE THIRD LoxP SITE
PCR was performed on SA positive clones to detect presence of
the third loxP site (5′-region of exon 4) using the LOX2 and
SDL2 primers. This reaction amplifies a 334-bp wild-type prod-
uct. The presence of a second PCR product 392 bp in size indicates
a positive loxP PCR. Positive clones were sequenced to confirm
sequence integrity and presence of the third loxP site using the
SDL2 primer.
RECONFIRMATION OF EXPANDED CLONES BY SOUTHERN BLOT
Four individual clones that had passed all controls were recon-
firmed by Southern blot analysis. DNA was digested with StuI,
and electrophoretically separated on a 0.8% agarose gel. After
transfer to a nylon membrane, the digested DNA was hybridized
with a probe targeted against the 5′ external region of the LA,
resulting in detection of two bands at 6.7 kb (targeted allele),
and 9.5 kb (wild-type allele). Positive clones were further con-
firmed by Southern blot analysis using an internal probe. DNA
was digested with PvuII, and electrophoretically separated. After
transfer to a nylon membrane, the digested DNA was hybridized
with a probe targeted against the 3′ internal region of the SA,
resulting in detection of two bands at 3.5 kb (targeted allele),
and 9.2 kb (wild-type allele). DNA from C57Bl/6 (B6), 129/SvEv
(129), and BA1 (C57Bl/6 × 129/SvEv) (Hybrid) mouse strains
were used as wild-type controls.
Targeted iTL BA1 hybrid embryonic stem cells were microin-
jected into C57BL/6 blastocysts. Resulting chimeras with a high
percentage of agouti coat color were mated to wild-type C57BL/6
homozygous Flp mice to remove the Neo cassette. Tail DNA was
analyzed from pups with agouti or black coat color. Presence of
the third loxP site was screened by PCR using LOX2 and SDL2
primers; presence and correct integration of the third loxP site was
also confirmed by sequencing using LOX2 primer. Presence and
confirmation of the SA was screened using primers A3 and F3,
resulting in a 2.5-kb amplification product. Primers NDEL1 and
NDEL2 were used to screen the genomic DNA for deletion of the
Neo cassette. This reaction amplifies a 492-bp wild-type product,
the presence of a second 675 bp PCR product indicates a targeted
allele with deletion of the Neo cassette. Presence of the Neo cas-
sette resulted in no amplification product because of its too big
size. Finally, heterozygous F1 mice with confirmed loxP-sites and
Neo deletion were back-crossed with C57/BL6 mice for 10 gen-
erations to obtain heterozygous mice with a >99.9% C57/BL6
background.
KNOCKDOWN OF NFAT5
Mice carrying an NFAT5 allele with a loxP-flanked exon
4 (NFAT5flx) were mated to the strain B6.Cg-Tg(UBC-
cre/ERT2)1Ejb/J (Jackson Laboratory, Bar Harbor, ME, USA)
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Table 1 | Oligonucleotides used in this study.
Name Sequence Purpose
P6 5′-GAG TGC ACC ATA TGG ACA TAT TGT C-3′ Gene targeting
T7 5′-CGA TAA GCC AGG TTA ACC TGC ATT A-3′ Gene targeting
N1 5′-TGC GAG GCC AGA GGC CAC TTG TGT AGC-3′ Gene targeting
N2 5′-TTC CTC GTG CTT TAC GGT ATC G-3′ Gene targeting
loxP 5′-TGA GAA ACA TGT ATG TGG GGC ATG-3′ Gene targeting
LOX2 5′-GTA ACC ATG ATT AGT CTT TTA GCT TTA TG-3′ Gene targeting, genotyping
SDL2 5′-GTT CTG AGA ATC CAA AGC ACA AC-3′ Gene targeting, genotyping
NDEL1 5′-GTT GTG CTT TGG ATT CTC AGA AC-3′ Gene targeting
NDEL2 5′-CTT CTA CCC TTC TAT TTC AGG AAG-3′ Gene targeting
A1 5′-CAC AAA TAC CTG CAA CAC CAG TGG-3′ Gene targeting
A2 5′-ACG CCA GTG TCA TGT TGT TG-3′ Gene targeting
A3 5′-GGA AAC AGA TAA CAT GCA TCA TAA ACA-3′ Gene targeting
AT1 5′-AAAT CGT AGG CTA GTA CTC CAC CC-3′ Gene targeting
AT2 5′-AGC TCA GGA AAA GCT TCC TG-3′ Gene targeting
F3 5′-GCA TAA GCT TGG ATC CGT TCT TCG GAC-3′ Gene targeting
F7 5′-GGA ACT TCG CTA GAC TAG TAC GCG TG-3′ Gene targeting
LUNI 5′-GCA TCG CCT TCT ATC GCC TTC TTG-3′ Gene targeting
PB1.1 5′-TTT TGT GGC TAA GCA CAGT CCC-3′ Southern blot probe
PB1.2 5′-CAT ACT GCA GCT CTG CTC AGA TCC-3′ Southern blot probe
PB2.1 5′-TGA CTG CCC TCA ACA GTT CAT TTG-3′ Southern blot probe
PB2.2 5′-ATT CAG GAT CTG CTA CCA CCA CTG-3′ Southern blot probe
Cre320 sense 5′-GAA CCT GAT GGA CAT GTT CA-3′ Genotyping
Cre320 anti 5′-AGT GCG TTC GAA CGC TAG AGC CTG T-3′ Genotyping
NFAT5 sense 5′-AAC ATT GGA CAG CCA AAA GG-3′ qRT-PCR analysis
NFAT5 anti 5′-GCA ACA CCA CTG GTT CAT TA-3′ qRT-PCR analysis
AR sense 5′-CTT AAA ATA TAA GCC TGC GGT GA-3′ qRT-PCR analysis
AR anti 5′-GCC TTT GCT GTG GCA GTA TT-3′ qRT-PCR analysis
BGT-1 sense 5′-GGC TCC TTT TGG TCA CAG AG-3′ qRT-PCR analysis
BGT-1 anti 5′-GCT GGA GGC GTA GTA GTC AAA-3′ qRT-PCR analysis
HSP70 sense 5′-TGA GTC CCA CAC TCT CAC CA-3′ qRT-PCR analysis
HSP70 anti 5′-CTG TGG GTG AAG CTG TTA AGG-3′ qRT-PCR analysis
β-Actin sense 5′-CTA AGG CCA ACC GTG AAA AG-3′ qRT-PCR analysis
β-Actin anti 5′-ACC AGA GGC ATA CAG GGA CA-3′ qRT-PCR analysis
harboring a Cre-ERT2 transgene under control of the ubiq-
uitinC promoter. Cre+ NFAT5flx/+ mice were interbred, and
Cre+ NFAT5flx/flx mice were used for knockdown of NFAT5. To
induce the knockdown, 6-week-old mice were fed a tamoxifen-
containing (400mg/kg) diet (Cre-active 400, Lasvendi, Soest,
Germany) for 4 weeks. Subsequently, mice were sacrificed, and
various tissues (kidney (cortex, outer medulla, inner medulla),
liver, heart, spleen, lung) were snap frozen in liquid nitrogen and
later analyzed for expression of NFAT5 and NFAT5 target genes.
All animal experiments were in accordance with the institutional
and the national guidelines and regulations. The experimental
procedures were approved by the institutional animal health and
care committee.
qRT-PCR ANALYSIS
For determination of NFAT5, AR, HSP70, BGT-1, and β-
actin mRNA expression levels, tissues were homogenized
in TRIFAST Reagent (Peqlab, Erlangen, Germany), and
RNA was isolated as recommended by the manufacturer.
Oligonucleotides used in this experiment are listed in Table 1.
Experiments were carried out on a Roche LightCycler 480,
using the SensiMix SYBR One-Step Kit (Bioline, Luckenwalde,
Germany) according to the manufacturer’s recommenda-
tions. Specificity of PCR product formation was confirmed
by monitoring melting point analysis and by agarose gel
electrophoresis.
IMMUNOBLOT ANALYSIS
Antibodies against NFAT5 and actin were obtained from Sigma
(Deisenhofen, Germany); antibody against HSP70 was obtained
from Stressgen (Victoria, Canada); antibody against rat lens
aldose reductase was a kind gift from Peter F. Kador. Tissues
were homogenized in 8M urea buffer. Aliquots (5–30μg pro-
tein) were subjected to sodium dodecylsulphate polyacrylamide
gel-electrophoresis (SDS-PAGE) and blotted onto nitrocellu-
lose membranes (Amersham Pharmacia Biotech, Little Chalfont,
Bucks., UK). Non-specific binding sites were blocked with 5%
non-fat dry milk in PBS containing 0.1% Tween-20 (PBS-T)
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FIGURE 1 | Generation of NFAT5 conditional null allele. (A) Schematic
figures of the wild-type NFAT5 allele, the targeting vector, and the
targeted NFAT5neo-flx , NFAT5flx , and NFAT5 alleles. Exons are
represented by open boxes in which the exon number is indicated. Black
triangles denote loxP sites; gray triangles denote frt sites. The 5′
homologous arm of the targeting vector is ∼5.25 kb, the 3′ homologous
arm ∼2.45 kb. P1 and P2 denote the location of the 5′- and the 3′-
external probe used for Southern blot analysis. Arrows indicate the
position of the primers used for gene targeting and genotyping.
NFAT5neo-flx mice were mated with Flp mice to generate NFAT5flx mice.
NFAT5 mice were generated by crossing NFAT5flx mice with transgenic
Cre mice and subsequent tamoxifen administration to targeted offspring.
(B) Southern blot analysis of NFAT5neo-flx/+ genomic DNA. 5′- and 3′-
external probes were used to detect the presence of the LA (5.25 kb)
and the SA (2.45 kb) of the targeted NFAT5 fragment. (C) Genotypes of
mice were identified using genomic DNA prepared from tail biopsies.
Primers LOX2 and SDL2 were used to distinguish the targeted allele
(392 bp) from the untargeted wild-type allele (334 bp).
at room temperature for 1 h. Samples were incubated with pri-
mary antibodies in PBS-T containing 5% non-fat dry milk over
night at 4◦C. Subsequently, the blots were washed 3 times with
PBS-T for 5min each. Subsequently, the membranes were incu-
bated with appropriate secondary antibody at room temperature
for 1 h in PBS-T containing 5% non-fat dry milk. After wash-
ing with PBS-T 3 times for 5min each, immunocomplexes were
visualized by enhanced chemiluminescence (Pierce, Rockford,
IL, USA).
STATISTICAL ANALYSES
Data are expressed as means ± SEM. The significance of differ-
ences between the means was assessed by Student’s t-test. P <
0.05 was regarded as significant. All experiments were performed
at least three times and representative results are shown.
RESULTS AND DISCUSSION
The murine NFAT5 gene is located on the plus (+) strand of
chromosome 8, spans about 86 kb, and is divided into 16 exons.
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FIGURE 2 | Expression of NFAT5 and NFAT5 target genes in the kidney.
Cre+ NFAT5flx/flx mice (or Cre+ NFAT5+/+ mice, as control) were fed a
tamoxifen-containing diet for 4 weeks to induce Cre-mediated excision of
exon 4 of the NFAT5 gene. Subsequently, animals were sacrificed and tissue
samples obtained from the renal cortex, outer medulla and inner medulla. (A)
mRNA from renal cortex (), outer medulla () and inner medulla () was
tested for transcription of NFAT5 and NFAT5 target genes AR, BGT-1 and
HSP70 by semiquantitative RT-PCR. Relative mRNA abundance was
normalized to that of β-actin to correct for differences in RNA input. Data are
means ± SEM for n = 4; ∗P < 0.05. (B) Protein samples from renal cortex,
outer medulla and inner medulla were tested for protein expression of NFAT5
and NFAT5 target genes AR and HSP70 by Western blot. To demonstrate
comparable protein loading, the blots were also probed for actin.
Representative blots from at least 4 independent experiments are shown.
FIGURE 3 | Expression of NFAT5 in various tissues of conditional
knockout mice. Cre+ NFAT5flx/flx mice () or Cre+ NFAT5+/+ mice (; as
control) were fed a tamoxifen-containing diet for 4 weeks to induce
Cre-mediated excision of exon 4 of the NFAT5 gene. Subsequently, tissue
samples from heart, liver, spleen, and skeletal muscle, were taken and
expression of NFAT5 was determined by semiquantitative qRT-PCR.
Relative mRNA abundance was normalized to that of β-actin to correct for
differences in RNA input. Data are means ± SEM for n = 4; ∗P < 0.05.
To generate a functional NFAT5-null allele in mice, exon 4 was
chosen as target for conditional deletion by insertion of flank-
ing loxP sites. Exon 4 shares 100% sequence homology with
the human NFAT5 exon 4, the perfect homology indicating a
highly conserved function for the protein sequence encoded by
this exon; additionally, deletion of exon 4 results in a frameshift
between exons 3 and 5. To generate the conditional NFAT5-null
(NFAT5flx) allele in mice, a genomic DNA fragment containing
the relevant region was isolated from the murine BAC library;
a loxP sequence was inserted 167 bp upstream from exon 4,
and an frt-flanked Neo expression cassette containing two loxP
sites was inserted 202 bp downstream from exon 4 to enable
positive selection (Figure 1A). The resulting target vector was
transfected into TL1 mouse embryonic stem (ES); then, the ES
cell colonies were selected with G418, screened via PCR and
Southern blot. Chimeric mice were generated by microinject-
ing NFAT5flx-neo/+ ES cells (Figure 1B) into C57BL/6 blasto-
cysts, and germline transmission was verified via obtaining F1
NFAT5flx-neo/+.offspring from crossing chimeric and C57/Bl6
mice. The F1 NFAT5flx-neo/+ mice were crossed with Flp mice
to remove the Neo cassette in the germ line and the NFAT5flx/+
offspring then backcrossed with C57/Bl6 wild-type mice over
10 generations to obtain mice with >99.9% C57/Bl6 back-
ground. Thereafter, NFAT5flx/+ mice were interbred, and the
offspring were genotyped via PCR (Figure 1C). The homozygous
NFAT5flx/flx mice appeared normal, were fertile, and were born
in the expected Mendelian ratio. NFAT5 expression, as analyzed
by qRT-PCR and immunoblotting, was comparable to C57/Bl6
wild-type mice (data not shown).
Next, homozygous NFAT5flx/flx mice were mated to B6.Cg-
Tg(UBC-cre/ERT2)1Ejb/J mice. This strain has strong tamoxifen-
inducible Cre activity in all reported tissue types. Expression of
the cre/ERT2 transgene is under control of the ubiquitin C pro-
moter. The Cre-ERT2 fusion protein consists of Cre recombinase
fused to a triple mutant form of the human estrogen recep-
tor, which does not bind its natural ligand (17β-estradiol) at
physiological concentrations but will bind the synthetic estrogen
receptor ligand tamoxifen. Restricted to the cytoplasm, Cre-ERT2
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can only gain access to the nucleus after exposure to tamox-
ifen, where Cre-mediated recombination will delete loxP-flanked
sequences from the genome. The offspring from this mating were
genotyped for the presence of the cre transgene and the NFAT5flx
allele, and interbred at the age of 8 weeks. Again, the offspring
from this mating were genotyped, and cre-positive, homozygous
NFAT5flx/flx mice were used for knockdown of NFAT5.
To induce the knockdown, Cre+ NFAT5flx/flx mice (or Cre+
NFAT5+/+ mice as control) were fed a tamoxifen-containing
diet for 4 weeks. Subsequently, the animals were sacrificed and
tissue samples prepared from liver, spleen, heart, skeletal mus-
cle, and kidney Kidney tissue samples were subdivided into
cortical, outer medullary, and inner medullary samples. Renal
expression of NFAT5 and the designated NFAT5 target genes
AR, HSP70, and BGT-1 was tested by semiquantitative RT-PCR
(Figure 2A) and immunoblot (Figure 2B). Highest expression of
NFAT5 and NFAT5 target genes in control animals was found
in inner medullary tissue samples, as expected. In knockout ani-
mals, NFAT5 expression was almost completely abolished in all
renal tissue sections whilst expression of NFAT5 target genes was
reduced significantly in the inner medulla. Expression in corti-
cal and outer medullary sections was largely unaffected. These
results indicate that Cre-mediated recombination of the NFAT5flx
allele indeed leads to a knockdown of NFAT5 and under the
tested conditions (H2O ad libitum), regulation of osmoprotec-
tive target genes by NFAT5 occurs predominantly in the inner
medulla, which is in accordance with previous studies (Lopez-
Rodriguez et al., 2004). NFAT5 expression in tissue samples of
heart, liver, spleen, and skeletal muscle was tested by qRT-PCR
(Figure 3), and expression levels were significantly decreased to
15–25% in NFAT5 knockout animals (compared with 100% in
control animals).
In the past, there have been attempts to analyze NFAT5 func-
tion in vivo by generation of conventional NFAT5 knockout
mice. These experiments clearly demonstrated the importance
of NFAT5 for embryonic development, however, there are severe
limitations on the use of these animals for defining the functions
of NFAT5 in adult animals. Conventional NFAT5−/− animals
show high embryonic and perinatal lethality. Until E14.5 no sig-
nificant deviation from the expected Mendelian ratios can be
observed in the number of NFAT5−/− embryos, while only 50%
of the expected number is obtained at E17.5, and only 3% at
P21 (Lopez-Rodriguez et al., 2004). NFAT5−/− embryos show
peripheral edema, probably due to abnormal heart development
as indicated by reduced cell density of the myocardium and thin-
ner ventricular wall (Mak et al., 2011). The few animals that reach
P21 show congenital growth retardation and suffer from renal
atrophy, probably due to decreased expression of NFAT5 target
genes like AR, HSP70, BGT-1, and SMIT during kidney develop-
ment (Lopez-Rodriguez et al., 2004). Hence, the kidney is already
severely damaged when the animals reach adulthood, and thus
research on NFAT5 function in the adult kidney, e.g., its role in
the urinary concentration mechanism, is severely restricted in
conventional NFAT5−/− mice. Moreover, these animals develop
an immune defect due to lymphoid hypocellularity and impaired
antigen-specific antibody responses (Go et al., 2004). Mice that
express a dominant-negative derivative of NFAT5 exhibit a 25%
reduction of CD4+ T-cells and a 50% reduction of CD8+ T-cells
(Trama et al., 2002).
Generally, the fact that NFAT5 has multiple physiological and
pathophysiological functions indicates that a conventional knock-
down is an inappropriate model for investigations on NFAT5
function in a specific cell type or tissue in vivo, since systemic
NFAT5 knockdown may generate unspecific side effects with
unpredictable impact on the tissue of interest. Modern Cre-Lox
recombination technology would appear to be an appropriate
means of overcoming this problem. Today, multiple mouse strains
are available, which express constitutively active or inducible Cre
recombinase with high specificity in individual cell types and tis-
sues, or at various developmental stages. Thus, combination of
such restricted Cre expression with the NFAT5flx allele described
in the present study will provide a useful tool for characteriz-
ing the tissue-type and cell type-specific functions of NFAT5 in
many developmental processes and diseases, as well as physio-
logical functions in adult animals, without the bias produced by
unspecific side effects of systemic knockdown.
CONCLUSIONS
Taken together, the results indicate that we have been able to gen-
erate a conditional NFAT5-null mutant mouse line. The NFAT5flx
allele retains the function of the wild-type gene, and inactive
NFAT5-null allele can be induced via Cre-mediated recombina-
tion. This will allow the study of NFAT5 function in specific cell
types and tissues in vivo.
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